Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

From injection therapies to natalizumab: views on the treatment of multiple sclerosis.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Tocilizumab, MS, and NMOSD.
Drugs to be Discontinued
Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.
Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use in the EU
IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability.
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
Paroxysmal Hypothermia in Two Patients with Multiple Sclerosis.
RNF and Betaseron® Tolerability Study (REFORMS)
Long term follow up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies.
Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial.
Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Vitamin D: a natural inhibitor of multiple sclerosis.
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab.
Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response.
Characterization of human platelet binding of recombinant T cell receptor ligand.
Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells.
Transverse myelitis associated with heroin and cannabis abuse: a new issue from the past.
Clinically isolated syndromes and the relationship to multiple sclerosis.

Pages